TanenbergRJ, NewtonCA, DrakeAJ. Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract, 2010; 16:244–248.
2.
McCrimmonR. The mechanisms that underlie glucose sensing during hypoglycaemia in diabetes. Diabet Med, 2008; 25:513–522.
ErichsenMM, LovasK, SkinningsrudB, WolffAB, UndlienDE, SvartbergJ, FougnerKJ, BergTJ, BollerslevJ, MellaB, CarlsonJA, ErlichH, HusebyeES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab, 2009; 94:4882–4890.
5.
BloodworthJMJr, KirkendallWM, CarrTL. Addison's disease associated with thyroid insufficiency and atrophy (Schmidt syndrome)J Clin Endocrinol Metab, 1954; 14:540–553.
6.
BleickenB, HahnerS, VentzM, QuinklerM. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci, 2010; 339:525–531.
7.
BergthorsdottirR, Leonsson-ZachrissonM, OdenA, JohannssonG. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab, 2006; 91:4849–4853.
8.
ErichsenMM, LovasK, FougnerKJ, SvartbergJ, HaugeER, BollerslevJ, BergJP, MellaB, HusebyeES. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol, 2009; 160:233–237.
9.
HahnerS, LoefflerM, BleickenB, DrechslerC, MilovanovicD, FassnachtM, VentzM, QuinklerM, AllolioB. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol, 2010; 162:597–602.
10.
FalorniA, NikoshkovA, LauretiS, GrenbackE, HultingAL, CasucciG, SanteusanioF, BrunettiP, LuthmanH, LernmarkA. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab, 1995; 80:2752–2755.
11.
FalorniA, ChenS, ZanchettaR, YuL, TibertiC, BacosiML, FurmaniakJ, BiniV, DottaF, EisenbarthGS, SmithBR, BetterleC. Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies. Clin Immunol, 2011; 140:291–299.
12.
BarkerJM, YuJ, YuL, WangJ, MiaoD, BaoF, HoffenbergE, NelsonJC, GottliebPA, RewersM, EisenbarthGS. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care, 2005; 28:850–855.
13.
BarkerJM, IdeA, HostetlerC, YuL, MiaoD, FainPR, EisenbarthGS, GottliebPA. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population. J Clin Endocrinol Metab, 2005; 90:128–134.
14.
TrioloTM, ArmstrongTK, McFannK, YuL, RewersMJ, KlingensmithGJ, EisenbarthGS, BarkerJM. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care, 2011; 34:1211–1213.
15.
CocoG, Dal PraC, PresottoF, AlbergoniMP, CanovaC, PediniB, ZanchettaR, ChenS, FurmaniakJ, Rees SmithB, ManteroF, BetterleC. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab, 2006; 91:1637–1645.
16.
TrioloTM, BaschalEE, ArmstrongTK, ToewsCS, FainPR, RewersMJ, YuL, MiaoD, EisenbarthGS, GottliebPA, BarkerJM. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. J Clin Endocrinol Metab, 2009; 94:4517–4523.
BetterleC, ScaliciC, PresottoF, PediniB, MoroL, RigonF, ManteroF. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol, 1988; 117:467–475.
19.
BakerPR, NanduriP, GottliebPA, YuL, KlingensmithGJ, EisenbarthGS, BarkerJM. Predicting the onset of Addison's disease: ACTH, renin, cortisol, 21-hydroxylase autoantibodies. Clin Endocrinol (Oxf), 2011Nov8[Epub ahead of print]10.1111/j.1365-2265.2011.04276.x.
20.
BabikerA, LeachER, DattaV. Should we screen children with type 1 diabetes for Addison's disease?Arch Dis Child, 2011; 96:700–701.
21.
MeyerG, HackemannA, ReuschJ, BadenhoopK. Nocturnal hypoglycemia identified by a continuous glucose monitoring system in patients with primary adrenal insufficiency (Addison's disease)Diabetes Technol Ther, 2012; 14:386–388.
